These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 27050147

  • 1. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y, Zheng Q, Dong Y, Xie X, Wang Y, Wu S, Zhang L, Wang Y, Xue T, Wang Z, Chen R, Wang Y, Cui J, Ren Z.
    Oncotarget; 2016 May 31; 7(22):32221-31. PubMed ID: 27050147
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway.
    Cao L, Fan X, Jing W, Liang Y, Chen R, Liu Y, Zhu M, Jia R, Wang H, Zhang X, Zhang Y, Zhou X, Zhao J, Guo Y.
    Oncotarget; 2015 Mar 30; 6(9):6627-40. PubMed ID: 25749383
    [Abstract] [Full Text] [Related]

  • 8. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M, Zhong C, Cui W, Wang G, Zheng G, Li L, Zhang J, Ren R, Gao H, Wang T, Li X, Che J, Gohda E.
    BMC Cancer; 2019 May 14; 19(1):439. PubMed ID: 31088527
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of matrix stiffness relating integrin β1 signaling pathway inhibits tumor growth in vitro and in hepatocellular cancer xenografts.
    Wang C, Jiang X, Huang B, Zhou W, Cui X, Zheng C, Liu F, Bi J, Zhang Y, Luo H, Yuan L, Yang J, Yu Y.
    BMC Cancer; 2021 Nov 25; 21(1):1276. PubMed ID: 34823500
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC, Tung SL, Chen YL, Chen PM, Chu PY.
    BMC Cancer; 2018 May 30; 18(1):609. PubMed ID: 29848298
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment.
    Kahraman DC, Kahraman T, Cetin-Atalay R.
    Mol Cancer Ther; 2019 Nov 30; 18(11):2146-2157. PubMed ID: 31439713
    [Abstract] [Full Text] [Related]

  • 15. Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.
    You Y, Zheng Q, Dong Y, Wang Y, Zhang L, Xue T, Xie X, Hu C, Wang Z, Chen R, Wang Y, Cui J, Ren Z.
    PLoS One; 2015 Nov 30; 10(8):e0134243. PubMed ID: 26280346
    [Abstract] [Full Text] [Related]

  • 16. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q, Chen K, Liu Z, Huang Y, Zhao R, Wei L, Yu X, He J, Liu J, Qi J, Qin Y, Li B.
    Cancer Lett; 2017 Sep 10; 403():165-174. PubMed ID: 28645561
    [Abstract] [Full Text] [Related]

  • 17. Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway.
    Huang G, Li L, Liang C, Yu F, Teng C, Pang Y, Wei T, Song J, Wang H, Liao X, Li Y, Yang J.
    Pharmacol Res Perspect; 2021 Feb 10; 9(1):e00720. PubMed ID: 33565716
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling.
    Liu F, Zhang W, Yang F, Feng T, Zhou M, Yu Y, Yu X, Zhao W, Yi F, Tang W, Lu Y.
    Sci Rep; 2016 Feb 16; 6():21260. PubMed ID: 26879559
    [Abstract] [Full Text] [Related]

  • 19. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
    Li L, Liu JD, Gao GD, Zhang K, Song YW, Li HB.
    Cancer Med; 2020 Sep 16; 9(17):6399-6410. PubMed ID: 32691991
    [Abstract] [Full Text] [Related]

  • 20. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.
    Liu B, Fang X, Kwong DL, Zhang Y, Verhoeft K, Gong L, Zhang B, Chen J, Yu Q, Luo J, Tang Y, Huang T, Ling F, Fu L, Yan Q, Guan XY.
    J Exp Clin Cancer Res; 2022 May 25; 41(1):182. PubMed ID: 35610614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.